Anti-Cancer Agents in Medicinal Chemistry
Title: Editorial [Hot Topic: Gold Derivatives as Anti-Cancer Agents (Guest Editor: Laura Rodriguez Raurell)]
Volume: 11 Issue: 10
Author(s): Laura Rodriguez Raurell
Affiliation:
Export Options
About this article
Cite this article as:
Rodriguez Raurell Laura, Editorial [Hot Topic: Gold Derivatives as Anti-Cancer Agents (Guest Editor: Laura Rodriguez Raurell)], Anti-Cancer Agents in Medicinal Chemistry 2011; 11 (10) . https://dx.doi.org/10.2174/187152011797927616
DOI https://dx.doi.org/10.2174/187152011797927616 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
An Integrated Platform for Bio-Analysis and Drug Delivery
Current Pharmaceutical Biotechnology The Use of α-Halo Ethers in the Protection of Alcohols. Years 2012 - 2014
Mini-Reviews in Organic Chemistry Meet Our Editorial Board Member
Recent Patents on Anti-Cancer Drug Discovery Targeting Cancer Metabolism as a Novel Anticancer Strategy
Current Topics in Medicinal Chemistry Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent
Anti-Cancer Agents in Medicinal Chemistry PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness
Anti-Cancer Agents in Medicinal Chemistry FAK and p53 Protein Interactions
Anti-Cancer Agents in Medicinal Chemistry Zebrafish as a Model Organism to Study Melatonin Mechanisms and Treatments
Current Psychopharmacology Nanoparticles in Biomedicine: New Insights from Plant Viruses
Current Medicinal Chemistry Transition Metal Complexes of Some Azamacrocycles and Their Use in Molecular Recognition
Current Organic Synthesis N-Oxides as Hypoxia Selective Cytotoxins
Mini-Reviews in Medicinal Chemistry Thiazoles and Thiazolidinones as Antioxidants
Current Medicinal Chemistry Aquaporins as Targets for Drug Discovery
Current Pharmaceutical Design Formulation Development and Characterization of Guar Gum Microspheres for Colon Delivery
Nanoscience & Nanotechnology-Asia Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer
Current Cancer Drug Targets Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Current Pharmaceutical Design Angiogenesis Inhibitors: Perspectives for Medical, Surgical and Radiation Oncology
Current Pharmaceutical Design Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine
Current Drug Targets